Skip to main content

Peer Review reports

From: Cost-effectiveness of ivosidenib versus chemotherapy for previously treated IDH1-mutant advanced intrahepatic cholangiocarcinoma in Taiwan

Original Submission
28 Jan 2024 Submitted Original manuscript
13 Feb 2024 Reviewed Reviewer Report
12 Mar 2024 Reviewed Reviewer Report - Sini Li
15 Apr 2024 Author responded Author comments - Yi-Wen Tsai
Resubmission - Version 2
15 Apr 2024 Submitted Manuscript version 2
16 Apr 2024 Reviewed Reviewer Report - Sini Li
8 May 2024 Reviewed Reviewer Report
Resubmission - Version 3
Submitted Manuscript version 3
Publishing
9 May 2024 Editorially accepted
22 May 2024 Article published 10.1186/s12885-024-12362-y

You can find further information about peer review here.

Back to article page